2012 Society of Surgical Oncology Cancer Symposium

Matthew Stenger / April 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Neoadjuvant Aromatase Inhibitor Therapy Converts Many Patients to Candidates for Breast-conserving Surgery

The American College of Surgeons Oncology Group (ACOSOG) Z1031 trial examined the effect of neoadjuvant aromatase inhibitor therapy on clinical response and breast-conservation rates in postmenopausal...

Breast Cancer

Matthew Stenger / May 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Inhibition of SFRP2 Found to Inhibit Growth of Triple-negative Breast Tumors

Secreted frizzled related protein 2 (SFRP2), a protein that modulates the Wnt signaling pathway and is involved in embryonic development, has been thought to exert a tumor-suppressive effect via inhib...

Hepatobiliary Cancer

Matthew Stenger / May 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Regional Infusion of Designer T Cells to Treat Intrahepatic Metastases

Designer T cells are modified from normal T cells to express specific immune receptors that allow them, via antibody-directed recognition or other mechanisms, to kill malignant cells bearing particula...

Oct

Today In Oncology

2012 Society of Surgical Oncology Cancer Symposium

Neoadjuvant Aromatase Inhibitor Therapy Converts Many Patients to Candidates for Breast-conserving Surgery

Inhibition of SFRP2 Found to Inhibit Growth of Triple-negative Breast Tumors

Regional Infusion of Designer T Cells to Treat Intrahepatic Metastases

IASLC 2017: Exercise Interventions in Advanced Lung Cancer Patients Led to Increased Functionality

IASLC 2017: Community Engagement Interventions May Reduce Disparities in Lung Cancer Outcomes Among Minorities

IASLC 2017: Non–Small Cell Lung Cancer Survival Rates Higher Among Patients Treated at Academic Centers

IASLC 2017: Poziotinib Yields High Response Rates in Patients With NSCLC With EGFR Exon 20 Insertion

Survival in Patients Treated With Adjuvant Chemoradiotherapy After Resection of Gastric Cancer

Sperm Banking for Adolescent Males With Newly Diagnosed Cancer

IASLC 2017: First-Line Pembrolizumab Increases Overall Survival vs Chemotherapy in Metastatic NSCLC With High Levels of PD-L1

FDA Approves CAR T-Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma

Immunotherapy for Previously Treated Advanced Gastric Cancer

FDA Approves CAR T-Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma

Combination Therapy for Patients With Advanced Unresectable Melanoma

Outcomes in Patients With Metastatic Lung Cancer Receiving PD-1/PD-L1 Inhibitors With Thoracic Radiotherapy

Survival in Patients Treated With Adjuvant Chemoradiotherapy After Resection of Gastric Cancer

IASLC 2017: CheckMate-032: Nivolumab Alone or With Ipilimumab in Recurrent SCLC With High Tumor Mutation Burden

IASLC 2017: Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non–Small Cell Lung Cancer

Addition of EGFR Tyrosine Kinase Inhibitor to Chemotherapy in Resistant Non–Small Cell Lung Cancer

A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?

PI3K Inhibition in Relapsed or Refractory Indolent Lymphoma